重视血管性肝病的认识与诊疗

唐承薇

doi:10.12449/JCH260401

重视血管性肝病的认识与诊疗

DOI: 10.12449/JCH260401

唐承薇^, ,

四川大学华西医院消化内科，成都 610041

利益冲突声明：本文不存在任何利益冲突。

详细信息

通信作者:
唐承薇， shcqcdmed@163.com （ORCID：0000-0002-2289-8420）

计量
- 文章访问数: 15
- HTML全文浏览量: 4
- PDF下载量: 3
- 被引次数: 0
出版历程
- 收稿日期: 2026-02-25
- 录用日期: 2026-03-09
- 出版日期: 2026-04-25

Raising awareness of vascular liver diseases： Diagnosis and treatment

Chengwei TANG^{,
,}

Department of Gastroenterology，West China Hospital，Sichuan University，Chengdu 610041，China

More Information

Corresponding author: TANG Chengwei， shcqcdmed@163.com （ORCID：0000-0002-2289-8420）

摘要

摘要: 各种致病因素导致肝动脉、门静脉、肝静脉、肝窦和淋巴管在内的肝脏血管系统损伤所引起的一组疾病被称为血管性肝病（VLD）。VLD在消化领域尚未得到应有的重视，导致部分肝病临床诊治困难。急性VLD常由危急重症和药物诱导。慢性VLD通常在其晚期、引起严重并发症时才获得临床诊断。肝活检和超声、多期计算机体层成像和磁共振成像对于诊断VLD至关重要。对VLD的病因、病理生理及临床诊治的探索，有助于从新的角度审视肝病的诊治思路，提高肝病诊治的整体水平。
- 血管性肝病 /
- 诊断 /
- 治疗学
Abstract: Vascular liver diseases （VLD） are defined as a group of diseases with damage of the liver vascular system including the hepatic artery， the portal vein， the hepatic vein， hepatic sinusoids and lymphatic vessels due to various pathogenic factors. VLD has not been fully understood in the field of gastroenterology， leading to difficulties in the clinical diagnosis and treatment of certain liver diseases. Acute VLD is often comorbid with critical illnesses and drug-induced conditions， while chronic VLD is usually diagnosed in its advanced stage or when it causes severe complications. Liver biopsy， ultrasound， multi-phase computed tomography， and magnetic resonance imaging are of great importance for the diagnosis of VLD. Exploration of the etiology， pathophysiology， diagnosis， and treatment of VLD can help to reexamine approaches to the diagnosis and treatment of liver diseases from a new perspective and improve the overall level of diagnosis and treatment of liver diseases.
- Vascular Liver Diseases /
- Diagnosis /
- Therapeutics

HTML全文

参考文献(14)

[1]	JONES J, TANER CB, O'DONNELL C, et al. Is there a place for deceased donor liver transplantation for colorectal metastases in the United States? Feasibility of a protocol utilizing machine perfusion[J]. Liver Transpl, 2026, 32( 2): 144- 152. DOI: 10.1097/LVT.0000000000000727.
[2]	WU JL, DENG XY, LUO JY, et al. Update in the treatment of cirrhotic patients with portal vein thrombosis[J]. Clin Mol Hepatol, 2025, 31( 4): 1139- 1166. DOI: 10.3350/cmh.2025.0411.
[3]	RELA M, RAMMOHAN A, RAJALINGAM R, et al. Portal hemodynamics in liver resection and transplantation[J]. Ann Surg, 2025, 281( 5): 764- 772. DOI: 10.1097/SLA.0000000000006304.
[4]	GILL RM, THEISE N. Vascular liver disease: Emerging concepts in the sinusoidal space[J]. Clin Liver Dis, 2025, 29( 3): 545- 561. DOI: 10.1016/j.cld.2025.03.008.
[5]	GAO JH, LAN T, KOSTALLARI E, et al. Angiocrine signaling in sinusoidal homeostasis and liver diseases[J]. J Hepatol, 2024, 81( 3): 543- 561. DOI: 10.1016/j.jhep.2024.05.014.
[6]	HAGIWARA S, IDA H, CHIKUGO T, et al. Peliosis hepatis complicated by Scleroderma and rapidly progressing to liver failure[J]. Intern Med, 2024, 63( 23): 3171- 3178. DOI: 10.2169/internalmedicine.3508-24.
[7]	VENKATESH SK, HARPER KC, BORHANI AA, et al. Hepatic sinusoidal disorders[J]. RadioGraphics, 2024, 44( 9): e240006. DOI: 10.1148/rg.240006.
[8]	SHALABY S, RAMÍREZ-QUESADA WE, OJEDA A, et al. Portosinusoidal vascular disorder: When to suspect and how to manage?[J]. Semin Liver Dis, 2025, 45( 4): 487- 497. DOI: 10.1055/a-2630-0848.
[9]	MEENA BL, RUDRA OS, SHARMA D, et al. Noncirrhotic portal hypertension: Current trends and future directions[J]. Curr Opin Gastroenterol, 2025, 41( 4): 271- 280. DOI: 10.1097/MOG.0000000000001106.
[10]	CIRIACI N, BERTIN L, RAUTOU PE. Genetic predisposition to Porto-sinusoidal vascular disorder[J]. Hepatology, 2026, 83( 2): 409- 424. DOI: 10.1097/HEP.0000000000000973.
[11]	BRUGÓS B, CSIRMAZ A, MAJOR T, et al. Antiangiogenic treatment of patients with hereditary hemorrhagic telangiectasia: Experience of a Hungarian center[J]. J Clin Med, 2025, 14( 22): 8160. DOI: 10.3390/jcm14228160.
[12]	SMITH JE, ROCKEY DC. Update on ischemic hepatitis[J]. Curr Opin Gastroenterol, 2024, 40( 3): 143- 147. DOI: 10.1097/MOG.0000000000001017.
[13]	KATIMS M, PINETON DE CHAMBRUN M, YELNIK C, et al. Vascular liver disorders in patients with antiphospholipid syndrome: A national retrospective multicentre study[J]. Rheumatology, 2025, 64( 8): 4614- 4621. DOI: 10.1093/rheumatology/keaf191.
[14]	MAINO C, VERNUCCIO F, CANNELLA R, et al. Cross-sectional imaging of congenital and acquired hepatic vascular abnormalities[J]. Eur J Radiol, 2025, 191: 112286. DOI: 10.1016/j.ejrad.2025.112286.